News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–7
Matches
7
Sources here
1
Companies here
2
Search results Stored financial headlines

Active search

7 matching headlines

Ticker or company: SDZMain company stories
Clear
Latest

finance.yahoo.com Deals and strategy

Sandoz targets industry patent void with $322m Henlius deal

Sandoz has entered a collaboration agreement with Shanghai Henlius Biotech that will see the two companies work together on a slew of new biosimilars. The deal is milestones-based for a total consideration of up to $322m, with near-term payments associated with the initial assets that could reach up to $100.5m. Under the agreement, the two companies will collaborate …

Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform

Collaboration may cover up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar assets, with the majority of programs at early development stages Based on the initial arrangements, the total invoiced amount expected to be achieved by Henlius in 2026 is up …

SDZ main company SDZ main company
Sharemaestro market context Trend signal active 43 weeks +45.5% · Next-week setup positive 56.0% SDZ stored weekly price path from 24 Oct 2025 to 14 Aug 2026

Sandoz Group AG (SDZNY) (H1 2026) Earnings Call Highlights: Biosimilar Growth Drives 5% Sales ...

This article first appeared on GuruFocus. Net Sales: Increased by 5% at constant currencies in H1 2026, reaching US$5.8 billion, up from US$5.2 billion in H1 2025. Biosimilar Sales: Grew by 20% in H1, accelerating to 22% in Q2, and reached a record 33% …

SDZ main company SDZ main company
Sharemaestro market context Trend signal active 43 weeks +45.5% · Next-week setup positive 56.0% SDZ stored weekly price path from 24 Oct 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Sandoz Group (SWX:SDZ) Settles US Drug Pricing Cases And Wins Brazil Semaglutide Approval

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Sandoz Group (SWX:SDZ) has agreed US settlements that resolve long running investigations into generic drug pricing. The company has received marketing authorisation in Brazil for Owozy, a …

SDZ main company SDZ main company
Sharemaestro market context Trend signal active 43 weeks +45.5% · Next-week setup positive 56.0% SDZ stored weekly price path from 24 Oct 2025 to 14 Aug 2026

UTHR or SDZNY: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Drugs stocks are likely familiar with United Therapeutics (UTHR) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. The best …

SDZ main company SDZ main company
Sharemaestro market context Trend signal active 43 weeks +45.5% · Next-week setup positive 56.0% SDZ stored weekly price path from 24 Oct 2025 to 14 Aug 2026

Sandoz strikes US settlements to resolve generic drug price dispute

Blister packs of medications by Sandoz, arranged as a Swiss cross. The Basel-based pharma group has reached two settlements in the United States (Fabrice COFFRINI) Swiss pharmaceutical group Sandoz on Monday announced two amicable settlements in the United States, totalling $478.5 million, to resolve …

SDZ main company SDZ main company
Sharemaestro market context Trend signal active 43 weeks +45.5% · Next-week setup positive 56.0% SDZ stored weekly price path from 24 Oct 2025 to 14 Aug 2026

Trump Proposes 200% Generic Drug Tariffs, Sandoz Shares Drop 4.2%

This article first appeared on GuruFocus. President Donald Trump has said generic drug manufacturers must move production to the United States or face a 100% import tariff from August 2028, with the levy set to rise to 200% in August 2029. The proposal is …

SDZ main company SDZ main company
Sharemaestro market context Trend signal active 43 weeks +45.5% · Next-week setup positive 56.0% SDZ stored weekly price path from 24 Oct 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context